Using portable air cleaners to improve heart failure outcomes
Official title: ACHIEVE GREATER: Addressing Cardiometabolic Health In Populations Through Early Prevention in the GREAT LakEs Region Project 4: Portable Air Cleaners to Treat Heart Failure and Negate Disparities of Environment and Race (PATHFINDER)
Run by Henry Ford Health System · NCT06070428 · Data updated 2026-11-12
This study is testing if giving portable air cleaners to heart failure patients when they leave the hospital can help them feel better by reducing their exposure to air pollution.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Henry Ford Health System Academic / other |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | December 18, 2023 |
| Main results expected | June 2027 |
| Study ends | June 2027 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT06070428 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are hospitalized heart failure patients who are being discharged and have elevated levels of BNP or NTproBNP.
✕Probably not a fit
Patients who are on hemodialysis, have a life expectancy of less than one year, or have a left ventricular assist device will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The ACHIEVE-P4: PATHFINDER project is a randomized, blinded clinical trial that provides portable air cleaners to heart failure patients at the time of hospital discharge. This study aims to assess whether reducing exposure to air pollution can improve clinical outcomes for these patients, particularly among those from disadvantaged backgrounds. Participants will be randomly assigned to receive either an active air cleaner or a sham device, and will also be provided with a PM2.5 sensor to monitor air quality in their homes. The trial is part of a broader initiative to address health disparities related to cardiometabolic conditions in urban populations.
Why it matters
Potential benefit: If successful, this intervention could significantly improve health outcomes and reduce hospital readmissions for heart failure patients exposed to high levels of air pollution.
How similar studies have gone: While the use of portable air cleaners is an emerging approach, previous studies have indicated that air pollution negatively impacts heart failure outcomes, suggesting potential for success in this novel intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Currently in the emergency room or hospitalized with plan to be discharged to home, or 2. Diagnosis of heart failure 3. BNP\>200 ng/L or NTproBNP\>1000 ng/L during hospitalization or within 1 month prior to screening 4. Expected ability to fully participate in study (can tolerate study processes, no long travel) Exclusion Criteria: 1. Hemodialysis dependent 2. If dialysis is being considered by participant's care team and their eGFR value is \<30 mL/min/1.73 sq m 3. Life expectancy of less than one year 4. Inability to provide written informed consent 5. Age less than 18 years old 6. Patients with a left ventricular assist device (LVAD) 7. Heart transplant recipients 8. Individuals who regularly use a HEPA air cleaner in their home at screening 9. Current smokers of nicotine or marijuana 10. Severe aortic or mitral valve disease 11. Has a scheduled, non-diagnostic cardiac procedure within 30 days prior, or in the next 90 days from screening (e.g. PCI, resynchronization, any cardiac surgery) 12. If the PI decides for any reason that participation in the trial is not in the best interest of the patient
Where it's running
-
Henry Ford Health
Detroit, Michigan, United States Recruiting
Study contacts
- Principal investigator: David Lanfear, MD — Henry Ford Health
- Study coordinator: Whitney Cabral, MS
- Email: WCABRAL1@hfhs.org
- Phone: 313-874-1887
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.